The use of high-dose acyclovir in patients with hematological malignancies who develop herpes virus infections: Is it really safe?

References (5)

1. Klassen TP, Belseck EM, Wiebe N, Hartling L. Acyclovir for treating varicella in otherwise healthy children and adolescents: a systematic review of randomised controlled trials. BMC Pediatr 2002;2(1):9-17
2. Sawyer MH, Webb DE, Balow JE, Straus SE. Acyclovir-induced renal failure. Clinical course and histology. Am J Med 1988;84(6):1067-71
3. Rajan GR, Cobb JP, Reiss CK. Acyclovir induced coma in the intensive care unit. Anaesth Intensive Care 2000;28(3);305-7
4. Rashiq S, Briewa L, Mooney M, Giancario T, Khatib R, Wilson FM. Distinguishing acyclovir neurotoxicity from encephalomyelitis. J Intern Med 1993;234(5);507-11
5. Adair JC, Gold M, Bond RE. Acyclovir neurotoxicity: clinical experience and review of the literature. South Med J 1994;87(12):1227-31. 6.Vomiero G, Carpenter B, Robb I, Filler G. Combination of ceftriaxone and acyclovir – an underestimated nephrotoxic potential? Pediatr Nephrol 2002;17(8): 633-7 7. Knegt RJ, van der Pijl H, van Es A. Acyclovir-associated encephalopathy, lack of relationship between acyclovir levels and symptoms. Nephrol Dial Transplant 1995;10(9):1775-7.